Predict your next investment

The High Note company logo
CONSUMER PRODUCTS & SERVICES
thehighnote.com

See what CB Insights has to offer

Stage

Private Equity | Alive

Total Raised

$15M

Last Raised

$15M | 3 yrs ago

About The High Note

The High Note is a cannabis company that cultivates, extracts, packages, distributes and sells its own, and third-party products.

The High Note Headquarter Location

5277 West Jefferson Blvd

Los Angeles, California, 90016,

United States

(213) 572-7199

Latest The High Note News

Q2 Earnings Preview - Entering The Season On High Note: IDBI Capital

Oct 7, 2021

07 Oct 2021, 6:28 PM IST 07 Oct 2021, 6:28 PM IST 07 Oct 2021, 6:28 PM IST Save BQ Blue’s special research section collates quality and in-depth equity and economy research reports from across India’s top brokerages, asset managers and research agencies. These reports offer BloombergQuint’s subscribers an opportunity to expand their understanding of companies, sectors and the economy. BQ Blue’s special research section collates quality and in-depth equity and economy research reports from across India’s top brokerages, asset managers and research agencies. These reports offer BloombergQuint’s subscribers an opportunity to expand their understanding of companies, sectors and the economy. IDBI Capital Report We expect Q2 FY22 earnings season to be strong on revenue growth on YoY basis but margin pressure to be there due to surge in costs across industries. Economic indicators have been healthy and point to sustained pick up in the economic activity in Q2 FY22. And thus we are not overtly concerned on the expected performance but yes growth rate could be plateauing from Q2 FY22. Nifty 50 has delivered 13% return in Q2 FY22 driven by improved sentiment from vaccination pick up, policy announcement (production linked incentive, telecom, monetisation pipeline) and good rainfall. We are entering the earning season on high note, and consensus is currently modeling Nifty 50 earnings per share to increase by 40%/11% YoY for FY22E/23E. Click on the attachment to read the full report: IDBI Capital Q2FY22 Earnings Preview.pdf View Document DISCLAIMER This report is authored by an external party. BloombergQuint does not vouch for the accuracy of its contents nor is responsible for them in any way. The contents of this section do not constitute investment advice. For that you must always consult an expert based on your individual needs. The views expressed in the report are that of the author entity and do not represent the views of BloombergQuint. Users have no license to copy, modify, or distribute the content without permission of the Original Owner.

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Research containing The High Note

Get data-driven expert analysis from the CB Insights Intelligence Unit.

CB Insights Intelligence Analysts have mentioned The High Note in 1 CB Insights research brief, most recently on Jun 14, 2019.

Expert Collections containing The High Note

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

The High Note is included in 1 Expert Collection, including Cannabis.

C

Cannabis

3,615 items

These companies participate in - or service businesses that participate in - the legal cannabis industry. Our definition of cannabis includes both marijuana and hemp (and all derivatives). The collection includes both "plant-touching" and "non-plant-touching" businesses.

The High Note Web Traffic

Rank
Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

The High Note Rank

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.